Indeed, K-Ras-driven tumors exposed to hyperglycemia in vivo grew faster than euglycemic hosts (at early time we, yet, observed tumor mass in STZ-treated mice, Figure 3A–B) and showed a more malignant growth behavior (Figure 3C). The gene discussed is KRAS; the disease is neoplasm.